Humoral Influence of Repeated Lineage‐Negative Stem/Progenitor Cell Administration on Articulatory Functions in ALS Patients

A Sobuś, B Baumert, W Pawlukowska… - Stem Cells …, 2020 - Wiley Online Library
Amyotrophic lateral sclerosis (ALS) remains a fatal, neurodegenerative disease frequently
leading to dysarthria and impaired swallowing. Better understanding of ALS …

Influence of Lineage‐Negative Stem Cell Therapy on Articulatory Functions in ALS Patients

W Pawlukowska, B Baumert… - Stem Cells …, 2019 - Wiley Online Library
Introduction. Amyotrophic lateral sclerosis (ALS) is a fatal, neurodegenerative disease,
leading to loss of muscle strength and motor control. Impaired speech and swallowing lower …

[HTML][HTML] Articulation recovery in ALS patients after lineage-negative adjuvant cell therapy-preliminary report

W Pawlukowska, B Baumert… - … Journal of Medical …, 2020 - ncbi.nlm.nih.gov
Background: Amyotrophic lateral sclerosis (ALS) is one of the most frequently occurring
neurodegenerative diseases affecting speech and swallowing. This preliminary study aimed …

Repeated application of autologous bone marrow-derived lineage-negative stem/progenitor cells—focus on immunological pathways in patients with ALS

B Baumert, A Sobuś, M Gołąb-Janowska… - Cells, 2020 - mdpi.com
Therapeutic interventions in amyotrophic lateral sclerosis (ALS) are still far from satisfying.
Immune modulating procedures raise hopes for slowing the disease progression. Stem cell …

Speech deterioration in amyotrophic lateral sclerosis (ALS) after manifestation of bulbar symptoms

T Makkonen, H Ruottinen, R Puhto… - … journal of language …, 2018 - Wiley Online Library
Background The symptoms and their progression in amyotrophic lateral sclerosis (ALS) are
typically studied after the diagnosis has been confirmed. However, many people with ALS …

Autologous bone marrow mononuclear cells as neuroprotective treatment of amyotrophic lateral sclerosis

FJ Ruiz-López, M Blanquer - Neural Regeneration Research, 2016 - journals.lww.com
Amyothrophic lateral sclerosis (ALS) is a disorder characterized by the progressive
degeneration of motoneurons and subsequent weakness of the skeletal muscles …

Local and systemic humoral response to autologous lineage-negative cells intrathecal administration in ALS patients

B Baumert, A Sobuś, M Gołąb-Janowska… - International Journal of …, 2020 - mdpi.com
Amyotrophic lateral sclerosis (ALS) remains a fatal disease with limited therapeutic options.
Signaling via neurotrophins (NTs), neuroinflammation, and certain micro-RNAs are believed …

Rate of speech decline in individuals with amyotrophic lateral sclerosis

M Eshghi, Y Yunusova, KP Connaghan, BJ Perry… - Scientific Reports, 2022 - nature.com
Although speech declines rapidly in some individuals with amyotrophic lateral sclerosis
(ALS), longitudinal changes in speech have rarely been characterized. The study objectives …

Stem cell therapy in amyotrophic lateral sclerosis

R Meamar, MH Nasr-Esfahani, SA Mousavi… - Journal of clinical …, 2013 - Elsevier
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder of upper and lower
motor neurons, characterized by progressive muscular atrophy and weakness which …

Overview of stem cells therapy in amyotrophic lateral sclerosis

G Je, K Keyhanian, M Ghasemi - Neurological Research, 2021 - Taylor & Francis
Background: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative
disease of upper and lower motor neurons with high burden on society. Despite tremendous …